Literature DB >> 26269621

Capsule Switching and Antimicrobial Resistance Acquired during Repeated Streptococcus pneumoniae Pneumonia Episodes.

Bin Chang1, Akiyoshi Nariai2, Tsuyoshi Sekizuka3, Yukihiro Akeda4, Makoto Kuroda3, Kazunori Oishi5, Makoto Ohnishi6.   

Abstract

Streptococcus pneumoniae colonizes the nasopharyngeal mucus in healthy people and causes otitis media, pneumonia, bacteremia, and meningitis. In this study, we analyzed an S. pneumoniae strain that caused 7 repeated pneumonia episodes in an 80-month-old patient with cerebral palsy during a period of 25 months. A total of 10 S. pneumoniae strains were obtained from sputum samples, and serotype 6B was isolated from samples from the first 5 episodes, whereas serotype 6A was isolated from samples from the last 2. Whole-genome sequencing showed clonality of the 10 isolates with 10 single nucleotide polymorphisms (SNPs) in the genomes. Among these SNPs, one single point mutation in the wciP gene was presumed to relate to the serotype switching from 6B to 6A, and the other mutations in parC and gyrA were related to fluoroquinolone resistance. These results suggested that an S. pneumoniae strain, which asymptomatically colonized the patient's nasopharynx or was horizontally transmitted from an asymptomatic carrier, caused the repeated pneumonia events. Phenotypic variations in the capsule type and antimicrobial susceptibility occurred during the carrier state. Hyporesponsiveness to serotypes 6B and 6A of S. pneumoniae was found even after vaccination with the 7-valent pneumococcal conjugate vaccine and the 23-valent pneumococcal polysaccharide vaccine. After an additional vaccination with the 13-valent pneumococcal conjugate vaccine, opsonic activities for both serotypes 6A and 6B significantly increased and are expected to prevent relapse by the same strain.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26269621      PMCID: PMC4572546          DOI: 10.1128/JCM.01222-15

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  31 in total

1.  Immunogenicity of alternative regimens of the conjugated 7-valent pneumococcal vaccine: a randomized controlled trial.

Authors:  Noga Givon-Lavi; David Greenberg; Ron Dagan
Journal:  Pediatr Infect Dis J       Date:  2010-08       Impact factor: 2.129

2.  Evolutionary genetics of the capsular locus of serogroup 6 pneumococci.

Authors:  Angeliki Mavroidi; Daniel Godoy; David M Aanensen; D Ashley Robinson; Susan K Hollingshead; Brian G Spratt
Journal:  J Bacteriol       Date:  2004-12       Impact factor: 3.490

3.  VarScan: variant detection in massively parallel sequencing of individual and pooled samples.

Authors:  Daniel C Koboldt; Ken Chen; Todd Wylie; David E Larson; Michael D McLellan; Elaine R Mardis; George M Weinstock; Richard K Wilson; Li Ding
Journal:  Bioinformatics       Date:  2009-06-19       Impact factor: 6.937

4.  A statistical framework for SNP calling, mutation discovery, association mapping and population genetical parameter estimation from sequencing data.

Authors:  Heng Li
Journal:  Bioinformatics       Date:  2011-09-08       Impact factor: 6.937

5.  Individual risk factors associated with nasopharyngeal colonization with Streptococcus pneumoniae and Haemophilus influenzae: a Japanese birth cohort study.

Authors:  Taketo Otsuka; Bin Chang; Takatoshi Shirai; Atsushi Iwaya; Akihito Wada; Noboru Yamanaka; Minoru Okazaki
Journal:  Pediatr Infect Dis J       Date:  2013-07       Impact factor: 2.129

6.  Immunogenicity following one, two, or three doses of the 7-valent pneumococcal conjugate vaccine.

Authors:  F M Russell; A Balloch; M L K Tang; J R Carapetis; P Licciardi; J Nelson; A W J Jenney; L Tikoduadua; L Waqatakirewa; J Pryor; G B Byrnes; Y B Cheung; E K Mulholland
Journal:  Vaccine       Date:  2009-07-17       Impact factor: 3.641

Review 7.  The fundamental link between pneumococcal carriage and disease.

Authors:  Birgit Simell; Kari Auranen; Helena Käyhty; David Goldblatt; Ron Dagan; Katherine L O'Brien
Journal:  Expert Rev Vaccines       Date:  2012-07       Impact factor: 5.217

8.  The incidence of pediatric invasive pneumococcal disease in Chiba prefecture, Japan (2003-2005).

Authors:  Naruhiko Ishiwada; Tomomichi Kurosaki; Itaru Terashima; Yoichi Kohno
Journal:  J Infect       Date:  2008-10-21       Impact factor: 6.072

9.  Nationwide population-based surveillance of invasive pneumococcal disease in Japanese children: Effects of the seven-valent pneumococcal conjugate vaccine.

Authors:  Shigeru Suga; Bin Chang; Kazutoyo Asada; Hideki Akeda; Junichiro Nishi; Kenji Okada; Hiroshi Wakiguchi; Akihiko Maeda; Megumi Oda; Naruhiko Ishiwada; Akihiko Saitoh; Tomohiro Oishi; Mitsuaki Hosoya; Takehiro Togashi; Kazunori Oishi; Toshiaki Ihara
Journal:  Vaccine       Date:  2015-07-31       Impact factor: 3.641

10.  Epidemiologic studies of Streptococcus pneumoniae in infants: acquisition, carriage, and infection during the first 24 months of life.

Authors:  B M Gray; G M Converse; H C Dillon
Journal:  J Infect Dis       Date:  1980-12       Impact factor: 5.226

View more
  9 in total

Review 1.  Streptococcus pneumoniae's Virulence and Host Immunity: Aging, Diagnostics, and Prevention.

Authors:  Lavida R K Brooks; George I Mias
Journal:  Front Immunol       Date:  2018-06-22       Impact factor: 7.561

2.  Epidemiological and clinical features of invasive pneumococcal disease caused by serotype 12F in adults, Japan.

Authors:  Reiko Shimbashi; Bin Chang; Yoshinari Tanabe; Hiroaki Takeda; Hiroshi Watanabe; Tetsuya Kubota; Kei Kasahara; Kengo Oshima; Junichiro Nishi; Takaya Maruyama; Koji Kuronuma; Jiro Fujita; Tatsuki Ikuse; Yuki Kinjo; Motoi Suzuki; Anusak Kerdsin; Tomoe Shimada; Munehisa Fukusumi; Keiko Tanaka-Taya; Tamano Matsui; Tomimasa Sunagawa; Makoto Ohnishi; Kazunori Oishi
Journal:  PLoS One       Date:  2019-02-21       Impact factor: 3.240

3.  Genome-wide analysis of Streptococcus pneumoniae serogroup 19 in the decade after the introduction of pneumococcal conjugate vaccines in Australia.

Authors:  Rebecca J Rockett; Shahin Oftadeh; Nathan L Bachmann; Verlaine J Timms; Fanrong Kong; Gwendolyn L Gilbert; Vitali Sintchenko
Journal:  Sci Rep       Date:  2018-11-16       Impact factor: 4.379

4.  Molecular analyses identifies new domains and structural differences among Streptococcus pneumoniae immune evasion proteins PspC and Hic.

Authors:  Shanshan Du; Cláudia Vilhena; Samantha King; Alfredo Sahagún-Ruiz; Sven Hammerschmidt; Christine Skerka; Peter F Zipfel
Journal:  Sci Rep       Date:  2021-01-18       Impact factor: 4.379

5.  Pneumococcal meningitis in adults in 2014-2018 after introduction of pediatric 13-valent pneumococcal conjugate vaccine in Japan.

Authors:  Bin Chang; Kosuke Tamura; Hiroyuki Fujikura; Hiroshi Watanabe; Yoshinari Tanabe; Koji Kuronuma; Jiro Fujita; Kengo Oshima; Takaya Maruyama; Shuichi Abe; Kei Kasahara; Junichiro Nishi; Tetsuya Kubota; Yuki Kinjo; Yusuke Serizawa; Reiko Shimbashi; Munehisa Fukusumi; Tomoe Shimada; Tomimasa Sunagawa; Motoi Suzuki; Kazunori Oishi
Journal:  Sci Rep       Date:  2022-02-23       Impact factor: 4.379

Review 6.  Emerging Roles of Extracellular Vesicles in Pneumococcal Infections: Immunomodulators to Potential Novel Vaccine Candidates.

Authors:  Saba Parveen; Karthik Subramanian
Journal:  Front Cell Infect Microbiol       Date:  2022-02-14       Impact factor: 5.293

7.  Progress toward a group B streptococcal vaccine.

Authors:  Joon Young Song; Jae Hyang Lim; Sangyong Lim; Zhi Yong; Ho Seong Seo
Journal:  Hum Vaccin Immunother       Date:  2018-07-16       Impact factor: 3.452

8.  Molecular serotype-specific identification of Streptococcus pneumoniae using loop-mediated isothermal amplification.

Authors:  Chika Takano; Yoko Kuramochi; Mitsuko Seki; Dong Wook Kim; Daisuke Omagari; Mari Sasano; Bin Chang; Makoto Ohnishi; Eun Jin Kim; Kazumasa Fuwa; Paul E Kilgore; Tomonori Hoshino; Satoshi Hayakawa
Journal:  Sci Rep       Date:  2019-12-27       Impact factor: 4.379

9.  Antibacterial activity of a DNA topoisomerase I inhibitor versus fluoroquinolones in Streptococcus pneumoniae.

Authors:  Myriam V Valenzuela; Mirian Domenech; Patricia Mateos-Martínez; Fernando González-Camacho; Adela G de la Campa; Maria Teresa García
Journal:  PLoS One       Date:  2020-11-03       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.